Effects of priorbevacizumab (B) use on outcomes from the VE-LOUR study: A phase III study of aflibercept (Afl)and FOLFIRI in patients (pts) with metastatic colo-rectal cancer (mCRC) after failure of an oxaliplatinregimen

查看全文 作　　者：Carmen J; Radek L;Josep T; 出　　处：《J Clin Oncol》索引2012年,共0页